SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns strong quarterly results and upbeat outlook, alongside AI-driven memory demand that management says will keep supply tight into 202728, are driving attention. Bulls see the supply constraints and customer commitments as support for a longer growth cycle, while others point to the muted post-earnings reaction, profit-taking, and macro pressure as reasons for caution.

Corteva, Inc. is a global pure-play agriculture company that combines innovative technologies, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. It generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. The company leverages recognized agricultural brands and a robust technology pipeline to maximize productivity for farmers while working with stakeholders throughout the food system to fulfill its promise of enriching the lives of those who produce and those who consume, ensuring progress for generations to come. Corteva was founded in 1802 and is headquartered in Indianapolis, IN.

Corteva Inc

Cortevas sharp apparent drop follows the completed spin-off of its seed and genetics business into Vylor, leaving CTVA as a standalone crop-protection company; traders are debating how to value the remaining business. Some see post-spin selling and confusion as an overreaction, while others argue the separation shifted much of the companys value to Vylor and expect further downside.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Evernorths approved business combination with Armada and planned Nasdaq listing as an XRP treasury company are driving attention, with traders also speculating that heavy redemptions could leave a smaller public float. The move has prompted bullish momentum and warrant-value chatter, alongside caution about volatility and the still-uncertain redemption count and warrant mechanics.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Googles Gemini 4 Argon launch is driving attention, with traders debating whether its reported benchmark strength can restore the companys position in the AI race. Some see the model as a positive catalyst, while others question its real-world advantage and monetization prospects, especially amid volatile price action.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is drawing attention amid selling pressure linked to scheduled IPO lockup share releases and insider sales, alongside reports that OpenAIs newest Ultrafast tier is using Nvidia GPUs rather than Cerebras hardware. Traders debate whether those developments threaten the OpenAI relationship and growth story, while bulls point to continued AI-inference demand and the companys broader customer and partnership pipeline.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOI is moving with a broader optical-connectivity rally after Cornings Verizon fiber agreement drew attention to the photonics sector. Traders also cite AI data-center demand for optical transceivers, while some remain concerned about ATM share sales and the stocks volatility.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

UMAC is drawing attention for a sharp selloff that traders say lacks a clear explanation; speculation about an offering is unconfirmed. The community also discusses the Pentagons planned Autonomous Warfare Command as a potential tailwind for drone suppliers, though that optimism has not prevented the pullback.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is drawing attention amid a semiconductor rally linked to Microns earnings and upbeat AI-related memory demand outlook. Traders are broadly buying dips, while others warn of profit-taking, volatility from the funds 3x leverage, and rising yields as risks.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Wells Fargos view that the recent AppLovin Pixel-install spike is concentrated in low-traffic Shopify storefronts, with no meaningful traffic-weighted pickup, has intensified concerns about the companys e-commerce expansion and accompanied a sharp selloff. Traders are divided between seeing the decline as an overreaction and buying an oversold stock, and warning that the weakness could continue until stronger growth evidence emerges.

Alphabet Inc - Ordinary Shares - Class C

Gemini 4 Argons launch has put Alphabets AI competitiveness in focus, but traders note that the shares sold off rather than sustaining a gain. The community is divided between seeing Argon as a potential boost to Googles AI standing and doubting that it can close the perceived gap with Meta, OpenAI, and Anthropic or translate technical progress into adoption and revenue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wedbush reiterated $JBIO Outperform-$47 after the Co. reported preliminary preclinical data for JADE301 at EADV and remained on track to kick off a Phase 1 healthy volunteer study in 4Q26. 
$PFE $ROIV AZN ARGX 
OTSKY TVTX VERA VRTX NVS 
Wedbush said in its note: Preclinical JADE301 data demonstrates ~3x longer half-life vs. dazukibart (PFE, not covered). Additionally, the JADE301 SC and IV doses demonstrated similar time/concentration profiles. Phase 1 results will better inform on human dosing and safety. 
 
Bottom line, we see the initial data appearing supportive. 
 
No change to our JBIO estimates as we continue to leave JADE301 as upside to our estimates. 
 
We look ahead to 2027 as an important turning point for JBIO with multiple readouts lining up including initial JUNIPER Phase 2 JADE101 data.

Stifel on $JBIO (Buy; $40): We&#39;re reiterating our Buy rating on JBIO following preclinical updates presented at EADV for recently-disclosed JADE301, a half-life extended anti-IFN-ẞ mAb for Dermatomyositis. 
$PFE $ROIV AZN ARGX 
OTSKY TVTX VERA ARWR 
NVS BIIB - RHHBY AMGN 
Here&#39;s what else Stifel had to say in its note to investors: https://x.com/Quantumup1/status/2105385653227721151?s=20

Stifel on $JBIO (Buy; $40): We're reiterating our Buy rating on JBIO following preclinical updates presented at EADV for recently-disclosed JADE301, a half-life extended anti-IFN-ẞ mAb for Dermatomyositis.$PFE $ROIV AZN ARGXOTSKY TVTX VERA ARWRNVS BIIB - RHHBY AMGNStifel... https://t.co/vafizMhuo7

quantumup on X (formerly Twitter): "Stifel on $JBIO (Buy; $40): We're reiterating our Buy rating on JBIO following preclinical updates presented at EADV for recently-disclosed JADE301, a half-life extended anti-IFN-ẞ mAb for Dermatomyositis.$PFE $ROIV ...

StockTwits Web

Jade Biosciences Inc

Pfizer Inc

Roivant Sciences Ltd

Quantumup

 Outperform-$47 after the Co. reported preliminary preclinical data for JADE301 at EADV and remained on track to kick off a Phase 1 healthy volunteer study in 4Q26. 


 AZN ARGX 
OTSKY TVTX VERA VRTX NVS 
Wedbush said in its note: Preclinical JADE301 data demonstrates ~3x longer half-life vs. dazukibart (PFE, not covered). Additionally, the JADE301 SC and IV doses demonstrated similar time/concentration profiles. Phase 1 results will better inform on human dosing and safety. 
 
Bottom line, we see the initial data appearing supportive. 
 
No change to our JBIO estimates as we continue to leave JADE301 as upside to our estimates. 
 
We look ahead to 2027 as an important turning point for JBIO with multiple readouts lining up including initial JUNIPER Phase 2 JADE101 data.